Skip to main content
Erschienen in: European Radiology 1/2016

01.01.2016 | Oncology

Accuracy and feasibility of estimated tumour volumetry in primary gastric gastrointestinal stromal tumours: validation using semiautomated technique in 127 patients

verfasst von: Sree Harsha Tirumani, Atul B. Shinagare, Ailbhe C. O’Neill, Mizuki Nishino, Michael H. Rosenthal, Nikhil H. Ramaiya

Erschienen in: European Radiology | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To validate estimated tumour volumetry in primary gastric gastrointestinal stromal tumours (GISTs) using semiautomated volumetry.

Methods

In this IRB-approved retrospective study, we measured the three longest diameters in x, y, z axes on CTs of primary gastric GISTs in 127 consecutive patients (52 women, 75 men, mean age 61 years) at our institute between 2000 and 2013. Segmented volumes (Vsegmented) were obtained using commercial software by two radiologists. Estimate volumes (V1–V6) were obtained using formulae for spheres and ellipsoids. Intra- and interobserver agreement of Vsegmented and agreement of V1–6 with Vsegmented were analysed with concordance correlation coefficients (CCC) and Bland–Altman plots.

Results

Median Vsegmented and V1–V6 were 75.9, 124.9, 111.6, 94.0, 94.4, 61.7 and 80.3 cm3, respectively. There was strong intra- and interobserver agreement for Vsegmented. Agreement with Vsegmented was highest for V6 (scalene ellipsoid, xyz), with CCC of 0.96 [95 % CI 0.95–0.97]. Mean relative difference was smallest for V6 (0.6 %), while it was −19.1 % for V5, +14.5 % for V4, +17.9 % for V3, +32.6 % for V2 and +47 % for V1.

Conclusion

Ellipsoidal approximations of volume using three measured axes may be used to closely estimate Vsegmented when semiautomated techniques are unavailable.

Key Points

Estimation of tumour volume in primary GIST using mathematical formulae is feasible.
Gastric GISTs are rarely spherical.
Segmented volumes are highly concordant with three axis-based scalene ellipsoid volumes.
Ellipsoid volume can be used as an alternative for automated tumour volumetry.
Literatur
2.
Zurück zum Zitat Tirumani SH, Jagannathan JP, Krajewski KM, Shinagare AB, Jacene H, Ramaiya NH (2013) Imatinib and beyond in gastrointestinal stromal tumors: a radiologist’s perspective. AJR Am J Roentgenol 201:801–810CrossRefPubMed Tirumani SH, Jagannathan JP, Krajewski KM, Shinagare AB, Jacene H, Ramaiya NH (2013) Imatinib and beyond in gastrointestinal stromal tumors: a radiologist’s perspective. AJR Am J Roentgenol 201:801–810CrossRefPubMed
3.
Zurück zum Zitat Miettinen M, Sobin LH, Lasota J (2005) Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 29:52–68CrossRefPubMed Miettinen M, Sobin LH, Lasota J (2005) Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 29:52–68CrossRefPubMed
4.
Zurück zum Zitat Gronchi A (2013) Risk stratification models and mutational analysis: keys to optimising adjuvant therapy in patients with gastrointestinal stromal tumour. Eur J Cancer 49:884–892CrossRefPubMed Gronchi A (2013) Risk stratification models and mutational analysis: keys to optimising adjuvant therapy in patients with gastrointestinal stromal tumour. Eur J Cancer 49:884–892CrossRefPubMed
5.
Zurück zum Zitat Tirumani SH, Shinagare AB, Jagannathan JP, Krajewski KM, Ramaiya NH, Raut CP (2014) Radiologic assessment of earliest, best, and plateau response of gastrointestinal stromal tumors to neoadjuvant imatinib prior to successful surgical resection. Eur J Surg Oncol 40:420–428CrossRefPubMed Tirumani SH, Shinagare AB, Jagannathan JP, Krajewski KM, Ramaiya NH, Raut CP (2014) Radiologic assessment of earliest, best, and plateau response of gastrointestinal stromal tumors to neoadjuvant imatinib prior to successful surgical resection. Eur J Surg Oncol 40:420–428CrossRefPubMed
6.
Zurück zum Zitat Wang D, Zhang Q, Blanke CD et al (2012) Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: long-term follow-up results of radiation therapy oncology group 0132. Ann Surg Oncol 19:1074–1080PubMedCentralCrossRefPubMed Wang D, Zhang Q, Blanke CD et al (2012) Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: long-term follow-up results of radiation therapy oncology group 0132. Ann Surg Oncol 19:1074–1080PubMedCentralCrossRefPubMed
7.
Zurück zum Zitat Miettinen M, Lasota J (2006) Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol 23:70–83CrossRefPubMed Miettinen M, Lasota J (2006) Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol 23:70–83CrossRefPubMed
8.
Zurück zum Zitat Rezai P, Pisaneschi MJ, Feng C, Yaghmai V (2013) A radiologist’s guide to treatment response criteria in oncologic imaging: anatomic imaging biomarkers. AJR Am J Roentgenol 201:237–245CrossRefPubMed Rezai P, Pisaneschi MJ, Feng C, Yaghmai V (2013) A radiologist’s guide to treatment response criteria in oncologic imaging: anatomic imaging biomarkers. AJR Am J Roentgenol 201:237–245CrossRefPubMed
9.
Zurück zum Zitat Nishino M, Dahlberg SE, Cardarella S et al (2013) Tumor volume decrease at 8 weeks is associated with longer survival in EGFR-mutant advanced non-small-cell lung cancer patients treated with EGFR TKI. J Thorac Oncol 8:1059–1068PubMedCentralCrossRefPubMed Nishino M, Dahlberg SE, Cardarella S et al (2013) Tumor volume decrease at 8 weeks is associated with longer survival in EGFR-mutant advanced non-small-cell lung cancer patients treated with EGFR TKI. J Thorac Oncol 8:1059–1068PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Nishino M, Dahlberg SE, Cardarella S et al (2013) Volumetric tumor growth in advanced non-small cell lung cancer patients with egfr mutations during EGFR-tyrosine kinase inhibitor therapy: developing criteria to continue therapy beyond recist progression. Cancer 119:3761–3768CrossRefPubMed Nishino M, Dahlberg SE, Cardarella S et al (2013) Volumetric tumor growth in advanced non-small cell lung cancer patients with egfr mutations during EGFR-tyrosine kinase inhibitor therapy: developing criteria to continue therapy beyond recist progression. Cancer 119:3761–3768CrossRefPubMed
11.
Zurück zum Zitat Schiavon G, Ruggiero A, Bekers DJ et al (2014) The effect of baseline morphology and its change during treatment on the accuracy of response evaluation criteria in solid tumours in assessment of liver metastases. Eur J Cancer 50:972–980CrossRefPubMed Schiavon G, Ruggiero A, Bekers DJ et al (2014) The effect of baseline morphology and its change during treatment on the accuracy of response evaluation criteria in solid tumours in assessment of liver metastases. Eur J Cancer 50:972–980CrossRefPubMed
12.
Zurück zum Zitat Schiavon G, Ruggiero A, Schoffski P et al (2012) Tumor volume as an alternative response measurement for imatinib treated GIST patients. PLoS One 7, e48372PubMedCentralCrossRefPubMed Schiavon G, Ruggiero A, Schoffski P et al (2012) Tumor volume as an alternative response measurement for imatinib treated GIST patients. PLoS One 7, e48372PubMedCentralCrossRefPubMed
13.
Zurück zum Zitat Schwartz L, Curran S, Trocola R et al (2007) Volumetric 3D CT analysis–an early predictor of response to therapy. J Clin Oncol 25:4576CrossRef Schwartz L, Curran S, Trocola R et al (2007) Volumetric 3D CT analysis–an early predictor of response to therapy. J Clin Oncol 25:4576CrossRef
14.
Zurück zum Zitat Nishino M, Guo M, Jackman DM et al (2011) CT tumor volume measurement in advanced non-small-cell lung cancer: performance characteristics of an emerging clinical tool. Acad Radiol 18:54–62PubMedCentralCrossRefPubMed Nishino M, Guo M, Jackman DM et al (2011) CT tumor volume measurement in advanced non-small-cell lung cancer: performance characteristics of an emerging clinical tool. Acad Radiol 18:54–62PubMedCentralCrossRefPubMed
15.
Zurück zum Zitat Nishino M, Jackman DM, DiPiro PJ, Hatabu H, Janne PA, Johnson BE (2014) Revisiting the relationship between tumour volume and diameter in advanced nsclc patients: an exercise to maximize the utility of each measure to assess response to therapy. Clin Radiol 69:841–848PubMedCentralCrossRefPubMed Nishino M, Jackman DM, DiPiro PJ, Hatabu H, Janne PA, Johnson BE (2014) Revisiting the relationship between tumour volume and diameter in advanced nsclc patients: an exercise to maximize the utility of each measure to assess response to therapy. Clin Radiol 69:841–848PubMedCentralCrossRefPubMed
16.
Zurück zum Zitat Chen SW, Yang SN, Liang JA, Tsai MH, Shiau AC, Lin FJ (2006) Value of computed tomography-based tumor volume as a predictor of outcomes in hypopharyngeal cancer after treatment with definitive radiotherapy. Laryngoscope 116:2012–2017CrossRefPubMed Chen SW, Yang SN, Liang JA, Tsai MH, Shiau AC, Lin FJ (2006) Value of computed tomography-based tumor volume as a predictor of outcomes in hypopharyngeal cancer after treatment with definitive radiotherapy. Laryngoscope 116:2012–2017CrossRefPubMed
17.
Zurück zum Zitat Chow DS, Qi J, Guo X et al (2014) Semiautomated volumetric measurement on postcontrast mr imaging for analysis of recurrent and residual disease in glioblastoma multiforme. AJNR Am J Neuroradiol 35:498–503CrossRefPubMed Chow DS, Qi J, Guo X et al (2014) Semiautomated volumetric measurement on postcontrast mr imaging for analysis of recurrent and residual disease in glioblastoma multiforme. AJNR Am J Neuroradiol 35:498–503CrossRefPubMed
18.
Zurück zum Zitat Lambregts DM, Rao SX, Sassen S et al (2014) Mri and diffusion-weighted MRI volumetry for identification of complete tumor responders after preoperative chemoradiotherapy in patients with rectal cancer: a bi-institutional validation study. Ann Surg. doi:10.1097/SLA.0000000000000909 Lambregts DM, Rao SX, Sassen S et al (2014) Mri and diffusion-weighted MRI volumetry for identification of complete tumor responders after preoperative chemoradiotherapy in patients with rectal cancer: a bi-institutional validation study. Ann Surg. doi:10.​1097/​SLA.​0000000000000909​
19.
Zurück zum Zitat Laubender R, Lynghjem J, D’Anastasi M et al (2014) Evaluating the agreement between tumour volumetry and the estimated volumes of tumour lesions using an algorithm. Eur Radiol 24:1521–1528CrossRefPubMed Laubender R, Lynghjem J, D’Anastasi M et al (2014) Evaluating the agreement between tumour volumetry and the estimated volumes of tumour lesions using an algorithm. Eur Radiol 24:1521–1528CrossRefPubMed
20.
Zurück zum Zitat Lee JA, Yang D, Yoon WS et al (2014) Tumor volume reduction assessed by planning computed tomography in patients with rectal cancer during preoperative chemoradiation: impact of residual tumor volume on the prediction of pathologic tumor regression. Tumori 100:158–162PubMed Lee JA, Yang D, Yoon WS et al (2014) Tumor volume reduction assessed by planning computed tomography in patients with rectal cancer during preoperative chemoradiation: impact of residual tumor volume on the prediction of pathologic tumor regression. Tumori 100:158–162PubMed
21.
Zurück zum Zitat Miller SL, Hoffer FA, Reddick WE et al (2001) Tumor volume or dynamic contrast-enhanced MRI for prediction of clinical outcome of ewing sarcoma family of tumors. Pediatr Radiol 31:518–523CrossRefPubMed Miller SL, Hoffer FA, Reddick WE et al (2001) Tumor volume or dynamic contrast-enhanced MRI for prediction of clinical outcome of ewing sarcoma family of tumors. Pediatr Radiol 31:518–523CrossRefPubMed
22.
Zurück zum Zitat Mozley PD, Bendtsen C, Zhao B et al (2012) Measurement of tumor volumes improves RECIST-based response assessments in advanced lung cancer. Transl Oncol 5:19–25PubMedCentralCrossRefPubMed Mozley PD, Bendtsen C, Zhao B et al (2012) Measurement of tumor volumes improves RECIST-based response assessments in advanced lung cancer. Transl Oncol 5:19–25PubMedCentralCrossRefPubMed
23.
Zurück zum Zitat Nixon IJ, Palmer FL, Lakin P, Kattan MM, Lee NY, Ganly I (2013) Pathologically determined tumor volume vs pathologic t stage in the prediction of outcome after surgical treatment of oropharyngeal squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg 139:1151–1155CrossRefPubMed Nixon IJ, Palmer FL, Lakin P, Kattan MM, Lee NY, Ganly I (2013) Pathologically determined tumor volume vs pathologic t stage in the prediction of outcome after surgical treatment of oropharyngeal squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg 139:1151–1155CrossRefPubMed
24.
Zurück zum Zitat Nougaret S, Rouanet P, Molinari N et al (2012) MR volumetric measurement of low rectal cancer helps predict tumor response and outcome after combined chemotherapy and radiation therapy. Radiology 263:409–418CrossRefPubMed Nougaret S, Rouanet P, Molinari N et al (2012) MR volumetric measurement of low rectal cancer helps predict tumor response and outcome after combined chemotherapy and radiation therapy. Radiology 263:409–418CrossRefPubMed
25.
Zurück zum Zitat Regini F, Gourtsoyianni S, Cardoso De Melo R et al (2014) Rectal tumour volume (GTV) delineation using T2-weighted and diffusion-weighted MRI: implications for radiotherapy planning. Eur J Radiol 83:768–772CrossRefPubMed Regini F, Gourtsoyianni S, Cardoso De Melo R et al (2014) Rectal tumour volume (GTV) delineation using T2-weighted and diffusion-weighted MRI: implications for radiotherapy planning. Eur J Radiol 83:768–772CrossRefPubMed
26.
Zurück zum Zitat Graser A, Becker CR, Reiser MF, Stief C, Staehler M (2008) Volumetry of metastases from renal cell carcinoma: comparison with the recist criteria. Radiologe 48:850–856CrossRefPubMed Graser A, Becker CR, Reiser MF, Stief C, Staehler M (2008) Volumetry of metastases from renal cell carcinoma: comparison with the recist criteria. Radiologe 48:850–856CrossRefPubMed
27.
Zurück zum Zitat Zhao B, Tan Y, Bell DJ et al (2013) Exploring intra- and inter-reader variability in uni-dimensional, bi-dimensional, and volumetric measurements of solid tumors on CT scans reconstructed at different slice intervals. Eur J Radiol 82:959–968CrossRefPubMed Zhao B, Tan Y, Bell DJ et al (2013) Exploring intra- and inter-reader variability in uni-dimensional, bi-dimensional, and volumetric measurements of solid tumors on CT scans reconstructed at different slice intervals. Eur J Radiol 82:959–968CrossRefPubMed
28.
Zurück zum Zitat Prasad SR, Jhaveri KS, Saini S, Hahn PF, Halpern EF, Sumner JE (2002) CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations. Radiology 225:416–419CrossRefPubMed Prasad SR, Jhaveri KS, Saini S, Hahn PF, Halpern EF, Sumner JE (2002) CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations. Radiology 225:416–419CrossRefPubMed
29.
Zurück zum Zitat Schramm N, Englhart E, Schlemmer M et al (2013) Tumor response and clinical outcome in metastatic gastrointestinal stromal tumors under sunitinib therapy: comparison of RECIST, Choi and volumetric criteria. Eur J Radiol 82:951–958CrossRefPubMed Schramm N, Englhart E, Schlemmer M et al (2013) Tumor response and clinical outcome in metastatic gastrointestinal stromal tumors under sunitinib therapy: comparison of RECIST, Choi and volumetric criteria. Eur J Radiol 82:951–958CrossRefPubMed
30.
Zurück zum Zitat Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205–216CrossRefPubMed Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205–216CrossRefPubMed
31.
Zurück zum Zitat Nishino M, Giobbie-Hurder A, Gargano M, Suda M, Ramaiya NH, Hodi FS (2013) Developing a common language for tumor response to immunotherapy: immune-related response criteria using unidimensional measurements. Clin Cancer Res 19:3936–3943PubMedCentralCrossRefPubMed Nishino M, Giobbie-Hurder A, Gargano M, Suda M, Ramaiya NH, Hodi FS (2013) Developing a common language for tumor response to immunotherapy: immune-related response criteria using unidimensional measurements. Clin Cancer Res 19:3936–3943PubMedCentralCrossRefPubMed
32.
Zurück zum Zitat Zhao B, James LP, Moskowitz CS et al (2009) Evaluating variability in tumor measurements from same-day repeat ct scans of patients with non-small cell lung cancer. Radiology 252:263–272PubMedCentralCrossRefPubMed Zhao B, James LP, Moskowitz CS et al (2009) Evaluating variability in tumor measurements from same-day repeat ct scans of patients with non-small cell lung cancer. Radiology 252:263–272PubMedCentralCrossRefPubMed
33.
Zurück zum Zitat Lin LI (1989) A concordance correlation coefficient to evaluate reproducibility. Biometrics 45:255–268CrossRefPubMed Lin LI (1989) A concordance correlation coefficient to evaluate reproducibility. Biometrics 45:255–268CrossRefPubMed
34.
Zurück zum Zitat Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307–310CrossRefPubMed Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307–310CrossRefPubMed
35.
Zurück zum Zitat Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: Revised recist guideline (version 1.1). Eur J Cancer 45:228–247CrossRefPubMed Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: Revised recist guideline (version 1.1). Eur J Cancer 45:228–247CrossRefPubMed
Metadaten
Titel
Accuracy and feasibility of estimated tumour volumetry in primary gastric gastrointestinal stromal tumours: validation using semiautomated technique in 127 patients
verfasst von
Sree Harsha Tirumani
Atul B. Shinagare
Ailbhe C. O’Neill
Mizuki Nishino
Michael H. Rosenthal
Nikhil H. Ramaiya
Publikationsdatum
01.01.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 1/2016
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-015-3829-6

Weitere Artikel der Ausgabe 1/2016

European Radiology 1/2016 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.